Clinical Use of Pathogen Reduced Red Blood Cell Suspension
Clinical trial NCT03426553 · COMPLETED
Trial details
- NCT number
- NCT03426553
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-15
- Primary completion
- 2018-09-17
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.